财务数据和关键指标变化 - 一季度净销售额和摊薄后每股收益环比增长，全球销售额和经营业绩处于内部预期范围内 [7] - 一季度运营利润率预期范围下调50个基点，主要因销售业绩杠杆下降，成本材料压力也有所上升 [21][22] - 一季度末进行了约2500万美元的股票回购活动 [34] 各条业务线数据和关键指标变化 - 恢复了活性营养产品线在部分市场的推广 [8] 各个市场数据和关键指标变化 - 美国市场实现同比销售增长，表现略超预期 [7] - 东南亚 - 太平洋地区部分关键市场在农历新年假期期间及之后业绩低于预期 [8] - 中国市场1月开局疲软，2月和3月有所回升 [14] - 菲律宾市场正努力扭转局面，业绩环比有所改善 [15] - 马来西亚市场因促销时间和农历新年因素，一季度表现不佳，但公司仍看好其未来发展 [16][17] - 美洲和欧洲地区按固定汇率计算下降约3%，主要因加拿大市场略有疲软，墨西哥市场面临竞争问题表现不佳 [30][31] 公司战略和发展方向和行业竞争 - 2022年推进多项战略举措，包括恢复活性营养产品线推广和通过战略数字投资提升客户体验 [8] - 面对中国市场挑战，公司将继续支持当地合作伙伴、客户和员工，并适应变化以推动业务发展 [10] - 针对通胀压力，公司在一季度中后期对多数市场进行了适度的价格调整，加权幅度在2% - 2.5% [20] 管理层对经营环境和未来前景的评论 - 公司认为尽管面临挑战，但全球战略的成功执行将使公司在未来实现长期可持续增长 [11] - 由于中国疫情升级及相关限制措施，公司预计中国市场业绩将受到负面影响，并下调了2022财年展望 [9][10] 其他重要信息 - 原计划9月在南京举办的线下活动改为混合形式，将利用内部媒体工作室制作高质量内容，并在全国分支机构举办小型线下聚会和分布式研讨会 [28] 总结问答环节所有的提问和回答 问题: 中国市场一季度进展及应对措施 - 中国市场1月开局疲软，2 - 3月因季度后期推出的多项举措而有所回升，公司对取得的成果感到满意 [14] 问题: 亚太地区马来西亚和菲律宾市场宏观趋势及生产力情况 - 菲律宾市场正努力扭转局面，业绩环比有所改善，但仍需努力；马来西亚市场因促销时间和农历新年因素一季度表现不佳，但公司仍看好其未来发展 [15][16][17] 问题: 原材料成本趋势及全年变化情况 - 目前仍处于之前提及的5% - 7%压力区间，公司运营团队会持续关注，后续会进行报告 [18] 问题: 是否进行价格调整及后续计划 - 一季度中后期对多数市场进行了适度价格调整，加权幅度在2% - 2.5%，以应对通胀压力 [20] 问题: 运营利润率下降原因及后续预期 - 一季度运营利润率下降主要因销售业绩杠杆下降，成本材料压力也有所上升 [21][22] 问题: 销售收入减少主要影响季度及原因 - 销售收入减少并非主要集中在二季度，去年二季度的短期项目今年进行了分散安排，中国市场虽面临挑战但二季度仍有望取得一定进展 [23][25][26] 问题: 疫情对产品销售和交付的影响 - 一季度因上海等地封锁，产品交付出现小波动，导致递延收入略有增加，公司一直在努力合规地解决产品交付问题 [27] 问题: 原计划中国线下活动是否有变化 - 原计划9月在南京举办的线下活动改为混合形式，将利用内部媒体工作室制作高质量内容，并在全国分支机构举办小型线下聚会和分布式研讨会 [28] 问题: 美洲和欧洲地区业绩下降原因 - 该地区按固定汇率计算下降约3%，主要因加拿大市场略有疲软，墨西哥市场面临竞争问题表现不佳 [30][31] 问题: 二季度收入环比情况 - 公司预计二季度收入将取得一定进展，但幅度不会很大 [32] 问题: 资产负债表新增少量债务原因 - 新增债务主要是由于运营中的时间安排问题，包括股票回购、资本或库存采购、支付年度奖金等，有时会有少量剩余债务 [34]

USANA Health Sciences, Inc. (NYSE:USNA) Q4 2021 Earnings Conference Call February 9, 2022 11:00 AM ET Company Participants Patrique Richards - Executive Director, Investor Relations and Business Development Kevin Guest - Chairman and Chief Executive Officer Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director of China Conference Call Participants Steph Wissink - Jefferies Doug Lane - Lane Research Disclaimer*: This transcript is designed to be used alongside the freely a ...

USANA Health Sciences, Inc. (NYSE:USNA) Q3 2021 Earnings Conference Call October 27, 2021 11:00 AM ET Company Participants Patrique Richards - Executive Director, IR & Business Development Kevin Guest - Chairman & CEO Douglas Hekking - CFO Jim Brown - President Conference Call Participants Douglas Lane - Lane Research Operator Good day, and welcome to the USANA Health Sciences Third Quarter Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. P ...

USANA Health Sciences, Inc. (NYSE:USNA) Q2 2021 Earnings Conference Call July 28, 2021 11:00 AM ET Company Participants Patrique Richards - Executive Director-Investor Relations & Business Development Kevin Guest - Chairman & Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Walter Noot - Chief Operating Officer Conference Call Participants Doug Lane - Lane Research Stephanie Wissink - Jefferies Ivan Feinseth - Tigress Financial Partners Operator Good day, and welcome to t ...

USANA Health Sciences, Inc. (NYSE:USNA) Q1 2021 Earnings Conference Call April 28, 2021 11:00 AM ET Corporate Participants Patrique Richards - Executive Director of Investor Relations & Business Development Kevin Guest - Chairman & Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director of China Conference Call Participants Doug Lane - Lane Research Sebastian Barbero - Jefferies Operator Good day, and welcome to the USANA Health ...

USANA Health Sciences, Inc. (NYSE:USNA) Q4 2020 Earnings Conference Call February 10, 2021 11:00 AM ET Company Participants Patrique Richards - Executive Director of Investor Relations & Business Development Kevin Guest - Chairman & Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Conference Call Participants David Bain - ROTH Capital Sebastian Barbero - Jefferies Doug Lane - Lane Research Ivan Feinseth - Tigress Financial Partners Operator Good day, and welcome to the US ...

业绩总结 - 2020年第三季度净销售额为2.985亿美元，同比增长15.2%[27] - 2020年第三季度每股摊薄收益为1.44美元，较2019年第三季度的1.09美元增长32.0%[27] - 2020年第三季度的营业利润率为21.5%，相比2019年第三季度的13.6%显著提升[27] - 2020年全年预计净销售额在10.90亿美元至11.15亿美元之间[30] - 2020年每股摊薄收益预计在5.15美元至5.45美元之间[30] - 2020年第三季度EBITDA为5100万美元，较2019年第三季度的4100万美元增长24.4%[27] - 2019年营收为10.61亿美元，2020年预计增长至10.95亿美元[23] 用户数据 - 截至2020年第三季度，活跃客户数量达到65万[4] - 2019年营收中，营养产品占比84%[15] 市场扩张 - 公司在24个国家销售60多种产品，专注于长期健康和保健[4]

USANA Health Sciences, Inc. (NYSE:USNA) Q3 2020 Earnings Conference Call October 21, 2020 11:00 AM ET Company Participants Patrique Richards – Executive Director of Investor Relations and Business Development Kevin Guest – Chairman and Chief Executive Officer Doug Hekking – Chief Financial Officer Conference Call Participants Doug Lane – Lane Research Sebastian Barbero – Jefferies Ivan Feinseth – Tigress Financial Partners Operator Good day, everyone, and welcome to the USANA Health SciencesÂ' Third Quarter ...

® THE CELLULAR NUTRITION COMPANY and and and a state 177 al i 20 t 7 4,28 23 Key | --- | --- | --- | |-------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Management will make forward-looking statements | | | | during this presentation. Actual results could differ | | | | from those projected in such forward-looking | | | | --- | --- | --- | |----------------------------------------------------------------------------------------- ...

USANA Health Sciences Inc. (NYSE:USNA) Q2 2020 Results Conference Call July 22, 2020 11:00 AM ET Company Participants Patrique Richards - Executive Director, Investor Relations & Business Development Kevin Guest - Chairman & Chief Executive Officer Doug Hekking - Chief Financial Officer Conference Call Participants Steph Wissink - Jefferies Doug Lane - Lane Research Ivan Feinseth - Tigress Financial Partners Operator Good day and welcome to the USANA Health Sciences' Second Quarter Conference Call. Today's ...